Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy

Ronald de Wit; J Herrstedt; B Rapoport; AD Carides; M Elmer; C Schmidt; JK Evans; KJ Horgan

Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy

Ronald de Wit, J Herrstedt, B Rapoport, AD Carides, M Elmer, C Schmidt, JK Evans, KJ Horgan

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

135 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	4105-4111
Number of pages	7
Journal	Journal of Clinical Oncology
Volume	21
Publication status	Published - 2003

Cite this

@article{c62751cf4ef147cdbbabeed3025775b0,

title = "Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy",

author = "{de Wit}, Ronald and J Herrstedt and B Rapoport and AD Carides and M Elmer and C Schmidt and JK Evans and KJ Horgan",

year = "2003",

language = "Undefined/Unknown",

volume = "21",

pages = "4105--4111",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy

AU - de Wit, Ronald

AU - Herrstedt, J

AU - Rapoport, B

AU - Carides, AD

AU - Elmer, M

AU - Schmidt, C

AU - Evans, JK

AU - Horgan, KJ

PY - 2003

Y1 - 2003

M3 - Article

VL - 21

SP - 4105

EP - 4111

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

ER -